· Periodic Report
Q3 operating profit KRW 27.1 billion on sales of KRW 76.8 billion
Myungin Pharm sold KRW 76.8 billion worth in Q3 and earned KRW 27.1 billion from its main business, up 23.5% from a year earlier and down 2.0% from the prior quarter.